Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Monika I. Leschinger"'
Autor:
Monika I. Leschinger, Helge Bischoff, Frank Langer, Francisco Luís Pimentel, Ben van den Borne, Nicholas Thatcher, Jorge Arellano
Publikováno v:
Current Medical Research and Opinion. 26:1461-1470
The ACTION (Assessment of Cost and ouTcomes of chemotherapy In an Observational setting) study investigated associations between chemotherapy, patient/disease characteristics and outcomes in advanced non-small cell lung cancer (NSCLC) patients in cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4660918aaafd129a733942b1d1e07b
https://doi.org/10.1185/03007991003799180
https://doi.org/10.1185/03007991003799180
Publikováno v:
Gemcitabin in der First-line-Therapie des lokal fortgeschrittenen und metastasierten nicht-kleinzelligen Bronchialkarzinoms (NSCLC): Ergebnis�bersicht randomisierter Phase-III-Studien
Beim fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom (NSCLC) erreichen moderne, platinbasierte Kombinationstherapien mit Gemcitabin, Vinorelbin oder Taxanen Ansprechraten von 30–40%, mediane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffffdd8016c328a172078e5cc5258164
https://doi.org/10.1159/000084364
https://doi.org/10.1159/000084364
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
There is convincing evidence for a specific BP-independent effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on albuminuria in glomerular disease. Because progression of glomerular disease is not consistently hal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c15848e920a4cebfade1e87254d5493
https://doi.org/10.1681/asn.v123602
https://doi.org/10.1681/asn.v123602
Autor:
Gerald Schmid-Bindert, Scott P. Myrand, Veronique Ripoche, Rebecca R. Hozak, Frank Mayer, Carla Visseren-Grul, Bente Frimodt-Moller, Kostas N. Syrigos, Diego Marquez-Medina, Annamaria Zimmermann, Monika I. Leschinger, Bonne Biesma, Wolfgang Schuette, Vittorio Gebbia, Edurne Arriola, Tuan S. Nguyen
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 81(3)
Objectives The aim was to determine if combined pemetrexed, cisplatin, and cetuximab was efficacious and safe as first-line treatment in advanced nonsquamous non-small cell lung cancer (NSCLC). Patients and methods In this single-arm, multicenter cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe3ea5dd9e24e7705bfd9c9547b92b9
https://pubmed.ncbi.nlm.nih.gov/23790468
https://pubmed.ncbi.nlm.nih.gov/23790468
Autor:
Folker Schneller, Thomas Müller, Sylvia Guetz, Andreas Gröschel, Wolfgang Schuette, Martin Reck, Martin Sebastian, C. Eschbach, Sabine Bohnet, Monika I. Leschinger, Stefan Andreas
Publikováno v:
Clinical lung cancer. 14(3)
Background Pemetrexed plus cisplatin was approved for first-line treatment of non–small-cell lung cancer (NSCLC) in patients with nonsquamous histology after initiation of this study. This phase II study evaluated pemetrexed plus cisplatin and peme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda4c10b1e76aeac2c24f16059ad2a41
https://pubmed.ncbi.nlm.nih.gov/23332288
https://pubmed.ncbi.nlm.nih.gov/23332288
Autor:
M. Klima, N. Vinolas, Durisala Desaiah, Christian Dittrich, Monika I. Leschinger, J. von Pawel, Zsolt Papai-Szekely, Christer Sederholm
Publikováno v:
Pneumologie. 66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abf4250f8ca75b9a2f40678c18387332
https://doi.org/10.1055/s-0032-1302878
https://doi.org/10.1055/s-0032-1302878
Autor:
Francesco Facciolo, Giorgio V. Scagliotti, Martin Hetzel, Lorenzo Spaggiari, Carla Visseren-Grul, Monika I. Leschinger, Johan Vansteenkiste, Tadeusz M. Orlowski, Ugo Pastorino, Valter Torri, Luigi Maiorino
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(2)
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine plus cisplatin followed by radical surgery provides a reduction in the risk of progression compared with surgery alone in patients with stages IB to IIIA non–sma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244b5093c152a2d91431922b3bdc1591
https://pubmed.ncbi.nlm.nih.gov/22124107
https://pubmed.ncbi.nlm.nih.gov/22124107
Autor:
Martin Reck, Wolfgang Schuette, Monika Serke, C. Eschbach, Joachim von Pawel, Monika I. Leschinger, Rolf A. Stahel, Meinolf Karthaus, Christian Manegold, Thomas H. Fink, Soenke Korfee
Publikováno v:
Respiratory medicine. 104(1)
An international expanded access program was initiated to provide access to treatment with pemetrexed prior registration and reimbursement for malignant mesothelioma (MM). Chemonaïve and pretreated patients with inoperable MM of the pleura or perito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a6a49965a688a3767e4029fd22b424
https://pubmed.ncbi.nlm.nih.gov/19818589
https://pubmed.ncbi.nlm.nih.gov/19818589
Autor:
Michael Thomas, C. Steppert, Juergen R. Fischer, M. Hamann, Monika I. Leschinger, Helge Bischoff, C. P. Schneider
Publikováno v:
Pneumologie. 59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab7168e753bdf2c3793fd47687c01cd1
https://doi.org/10.1055/s-2005-864311
https://doi.org/10.1055/s-2005-864311
Autor:
Marco Maggiorini, Roland B. Walter, Stephan R. Vavricka, Monika I. Leschinger, Esther B. Bachli
Publikováno v:
Intensive care medicine. 29(2)
wards normalization. Similarly, the extent of skin necrosis declined markedly, and in three patients full recovery was achieved. One patient lost three toes on both feet, but all other digits recovered fully. No complications that could be attributed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b40aa4255f00e80fe38c90e04b27cbd
https://pubmed.ncbi.nlm.nih.gov/12594601
https://pubmed.ncbi.nlm.nih.gov/12594601